GAO: FDA yet to make safety changes post-Vioxx
The Food and Drug Administration still hasn’t restructured its staff to better monitor drug safety, more than three years after experts recommended key changes in the wake of the Vioxx scandal.
December 9, 2009
Canadian Vioxx study challenges Merck
A Canadian study involving thousands of Vioxx patients concluded they faced the highest risk of heart attack during the first few weeks of taking Merck's arthritis painkiller.
Guardian Unlimited | Life | How do we stop the Vioxx disaster happening again? (Guardian Unlimited)
How do we stop the Vioxx disaster happening again? This question is exercising the minds of drug companies and scientists alike. A report in this week's Lancet estimates there are 140,000 people with serious heart disease in the US caused by use of the painkiller Vioxx.
Merck's defense in Vioxx trial back on track
ATLANTIC CITY, N.J. Jurors at the Vioxx trial in Atlantic City, New Jersey, are hearing from a doctor who works for the drug maker Merck and Company.
